Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
| Revenue (TTM) | $1.50B |
| Gross Profit (TTM) | $488.62M |
| EBITDA | $234.75M |
| Operating Margin | 12.60% |
| Return on Equity | 30.30% |
| Return on Assets | 8.40% |
| Revenue/Share (TTM) | $37.00 |
| Book Value | $8.92 |
| Price-to-Book | 3.73 |
| Price-to-Sales (TTM) | 0.88 |
| EV/Revenue | 1.373 |
| EV/EBITDA | 9.28 |
| Quarterly Earnings Growth (YoY) | 15.70% |
| Quarterly Revenue Growth (YoY) | 10.30% |
| Shares Outstanding | $21.07M |
| Float | $20.87M |
| % Insiders | 0.85% |
| % Institutions | 99.77% |
Volatility is currently contracting
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Investors need to pay close attention to PAHC stock based on the movements in the options market lately.
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 27, 2026, at 9:45 AM ET at Lotte New York Palace in New York. The live audio presentation will be available on the.
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks is more attractive to value investors?
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Review Phibro's (PAHC) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
